1. Home
  2. OTTR vs ACLX Comparison

OTTR vs ACLX Comparison

Compare OTTR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTTR
  • ACLX
  • Stock Information
  • Founded
  • OTTR 1907
  • ACLX 2015
  • Country
  • OTTR United States
  • ACLX United States
  • Employees
  • OTTR N/A
  • ACLX N/A
  • Industry
  • OTTR Electric Utilities: Central
  • ACLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OTTR Utilities
  • ACLX Health Care
  • Exchange
  • OTTR Nasdaq
  • ACLX Nasdaq
  • Market Cap
  • OTTR 3.5B
  • ACLX 3.3B
  • IPO Year
  • OTTR N/A
  • ACLX 2022
  • Fundamental
  • Price
  • OTTR $78.96
  • ACLX $62.02
  • Analyst Decision
  • OTTR
  • ACLX Strong Buy
  • Analyst Count
  • OTTR 0
  • ACLX 13
  • Target Price
  • OTTR N/A
  • ACLX $110.82
  • AVG Volume (30 Days)
  • OTTR 337.4K
  • ACLX 799.4K
  • Earning Date
  • OTTR 05-05-2025
  • ACLX 05-08-2025
  • Dividend Yield
  • OTTR 2.65%
  • ACLX N/A
  • EPS Growth
  • OTTR 2.43
  • ACLX N/A
  • EPS
  • OTTR 7.17
  • ACLX N/A
  • Revenue
  • OTTR $1,330,548,000.00
  • ACLX $107,936,000.00
  • Revenue This Year
  • OTTR $2.59
  • ACLX N/A
  • Revenue Next Year
  • OTTR $4.32
  • ACLX $96.17
  • P/E Ratio
  • OTTR $11.01
  • ACLX N/A
  • Revenue Growth
  • OTTR N/A
  • ACLX N/A
  • 52 Week Low
  • OTTR $71.66
  • ACLX $47.88
  • 52 Week High
  • OTTR $100.84
  • ACLX $107.37
  • Technical
  • Relative Strength Index (RSI)
  • OTTR 48.29
  • ACLX 47.82
  • Support Level
  • OTTR $77.93
  • ACLX $59.38
  • Resistance Level
  • OTTR $80.71
  • ACLX $61.52
  • Average True Range (ATR)
  • OTTR 2.69
  • ACLX 4.80
  • MACD
  • OTTR 0.04
  • ACLX 0.09
  • Stochastic Oscillator
  • OTTR 70.99
  • ACLX 70.31

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

About ACLX Arcellx Inc.

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Share on Social Networks: